Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro

被引:76
作者
Caraher, E.
Reynolds, G.
Murphy, P.
McClean, S.
Callaghan, M. [1 ]
机构
[1] ITT, Dept Appl Sci, Dublin 24, Ireland
[2] ITT, NICB, Dublin 24, Ireland
[3] Adelaide Meath Inc Natl Childrens Hosp AMNCH, Dublin 24, Ireland
[4] Trinity Coll Dublin, Dept Clin Microbiol, Dublin 2, Ireland
关键词
D O I
10.1007/s10096-007-0256-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study determined the antibiotic susceptibility of planktonic and biofilm cultures of Burkholderia cepacia complex organisms, a group of highly problematic pathogens associated with cystic fibrosis patients. The biofilm inhibitory concentrations were considerably higher than the corresponding minimum inhibitory concentrations for meropenem and piperacillin-tazobactam. However, tobramycin and amikacin were efficacious against both biofilm and planktonic cultures. Overall this study showed that biofilm susceptibility testing might be more clinically appropriate for determining antibiotic therapy for Burkholderia cepacia complex infections in cystic fibrosis patients.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 15 条
[1]   Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis [J].
Aaron, SD ;
Ferris, W ;
Ramotar, K ;
Vandemheen, K ;
Chan, F ;
Saginur, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4172-4179
[2]   Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia [J].
Burns, JL ;
Jonas, M ;
Chi, EY ;
Clark, DK ;
Berger, A ;
Griffith, A .
INFECTION AND IMMUNITY, 1996, 64 (10) :4054-4059
[3]   Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans [J].
Caraher, Emma ;
Duff, Caroline ;
Mullen, Tracy ;
Mc Keon, Suzanne ;
Murphy, Philip ;
Callaghan, Maire ;
McClean, Siobhan .
JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (01) :49-56
[4]   Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth [J].
Desai, M ;
Bühler, T ;
Weller, PH ;
Brown, MRW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :153-160
[5]   Biofilms: Survival mechanisms of clinically relevant microorganisms [J].
Donlan, RM ;
Costerton, JW .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (02) :167-+
[6]   A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis [J].
Hodson, ME ;
Gallagher, CG ;
Govan, JRW .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (03) :658-664
[7]   PSEUDOMONAS CEPACIA INFECTION IN CYSTIC-FIBROSIS - AN EMERGING PROBLEM [J].
ISLES, A ;
MACLUSKY, I ;
COREY, M ;
GOLD, R ;
PROBER, C ;
FLEMING, P ;
LEVISON, H .
JOURNAL OF PEDIATRICS, 1984, 104 (02) :206-210
[8]   Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis [J].
Kalish, LA ;
Waltz, DA ;
Dovey, M ;
Potter-Bynoe, G ;
McAdam, AJ ;
LiPuma, JJ ;
Gerard, C ;
Goldmann, D .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (04) :421-425
[9]   Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis [J].
LiPuma, JJ ;
Spilker, T ;
Gill, LH ;
Campbell, PW ;
Liu, LX ;
Mahenthiralingam, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (01) :92-96
[10]   Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis [J].
Moskowitz, SM ;
Foster, JM ;
Emerson, J ;
Burns, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) :1915-1922